These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9608563)

  • 1. Myoblast transplantation in non-dystrophic dog.
    Ito H; Vilquin JT; Skuk D; Roy B; Goulet M; Lille S; Dugré FJ; Asselin I; Roy R; Fardeau M; Tremblay JP
    Neuromuscul Disord; 1998 Apr; 8(2):95-110. PubMed ID: 9608563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myoblast transplantation in monkeys: control of immune response by FK506.
    Kinoshita I; Roy R; Dugré FJ; Gravel C; Roy B; Goulet M; Asselin I; Tremblay JP
    J Neuropathol Exp Neurol; 1996 Jun; 55(6):687-97. PubMed ID: 8642394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression.
    Kinoshita I; Vilquin JT; Guérette B; Asselin I; Roy R; Tremblay JP
    Muscle Nerve; 1994 Dec; 17(12):1407-15. PubMed ID: 7526208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice.
    Camirand G; Caron NJ; Asselin I; Tremblay JP
    Transplantation; 2001 Jul; 72(1):38-44. PubMed ID: 11468532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans.
    Skuk D; Goulet M; Roy B; Tremblay JP
    Exp Neurol; 2002 May; 175(1):112-26. PubMed ID: 12009764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice.
    Guerette B; Gingras M; Wood K; Roy R; Tremblay JP
    Transplantation; 1996 Oct; 62(7):962-7. PubMed ID: 8878391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation.
    Kinoshita I; Huard J; Tremblay JP
    Muscle Nerve; 1994 Sep; 17(9):975-80. PubMed ID: 8065399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoblast transplantation in whole muscle of nonhuman primates.
    Skuk D; Goulet M; Roy B; Tremblay JP
    J Neuropathol Exp Neurol; 2000 Mar; 59(3):197-206. PubMed ID: 10744058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by anti-LFA-1 of acute myoblast death following transplantation.
    Guérette B; Skuk D; Célestin F; Huard C; Tardif F; Asselin I; Roy B; Goulet M; Roy R; Entman M; Tremblay JP
    J Immunol; 1997 Sep; 159(5):2522-31. PubMed ID: 9278346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of increasing dystrophin-positive myofibers by myoblast transplantation: study using mdx/beta-galactosidase transgenic mice.
    Kinoshita I; Vilquin JT; Tremblay JP
    Acta Neuropathol; 1996; 91(5):489-93. PubMed ID: 8740229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intramuscular migration of myoblasts transplanted after muscle pretreatment with metalloproteinases.
    Torrente Y; El Fahime E; Caron NJ; Bresolin N; Tremblay JP
    Cell Transplant; 2000; 9(4):539-49. PubMed ID: 11038070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful myoblast transplantation in primates depends on appropriate cell delivery and induction of regeneration in the host muscle.
    Skuk D; Roy B; Goulet M; Tremblay JP
    Exp Neurol; 1999 Jan; 155(1):22-30. PubMed ID: 9918701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human myoblast transplantation in immunodeficient and immunosuppressed mice: evidence of rejection.
    Huard J; Roy R; Guérette B; Verreault S; Tremblay G; Tremblay JP
    Muscle Nerve; 1994 Feb; 17(2):224-34. PubMed ID: 8114793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation.
    Guérette B; Asselin I; Skuk D; Entman M; Tremblay JP
    Cell Transplant; 1997; 6(2):101-7. PubMed ID: 9142441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice.
    Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
    Muscle Nerve; 1995 Jan; 18(1):39-51. PubMed ID: 7799997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice.
    Leriche-Guérin K; Anderson LV; Wrogemann K; Roy B; Goulet M; Tremblay JP
    Neuromuscul Disord; 2002 Feb; 12(2):167-73. PubMed ID: 11738359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx mice.
    Kinoshita I; Vilquin JT; Tremblay JP
    Muscle Nerve; 1995 Aug; 18(8):834-41. PubMed ID: 7630343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of nls beta-galactosidase as a marker for studying myogenic lineage or the efficacy of myoblast transfer.
    Yang J; Ontell MP; Kelly R; Watkins SC; Ontell M
    Anat Rec; 1997 May; 248(1):40-50. PubMed ID: 9143666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.
    Rando TA; Blau HM
    J Cell Biol; 1994 Jun; 125(6):1275-87. PubMed ID: 8207057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
    Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP
    J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.